Colman Carol L sold $16.5K of HIO, trimming their stake 18%.
COLMAN CAROL L
Director · SEC CIK 1240474Buy track record
How this insider's open-market purchases have performed| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | EMO | $11 | $21.7K | +67% | −5.5% | +7.7% | +12.8% | −3.8% | +87.3% | |
| Mar 8, 2018 | EMO | $11 | $32K | NEW | −6.2% | +8.3% | +13.2% | −3.2% | +91.0% | |
| Jun 6, 2016 | GDO | $17 | $13.8K | NEW | +2.4% | +5.2% | +1.9% | +13.3% | +52.7% | |
| Sep 6, 2013 | CBA | $19 | $37.8K | NEW | +0.0% | +0.0% | +0.0% | +0.0% | +20.0% | |
| Sep 28, 2012 | EHI | $14 | $41.3K | +263% | +0.0% | +0.0% | +0.0% | +0.0% | +67.2% | |
| Mar 12, 2012 | DMO | $22 | $32.5K | +107% | +0.0% | +0.0% | +0.0% | +0.0% | +52.5% | |
| Aug 26, 2010 | DMO | $20 | $28.1K | NEW | +0.0% | +0.0% | +0.0% | +0.0% | +52.5% | |
| Jul 23, 2009 | HIO | $5 | $21.3K | +19% | +0.0% | +0.0% | +0.0% | +0.0% | +76.9% | |
| Jun 4, 2009 | HIO | $5 | $39K | +55% | +0.0% | +0.0% | +0.0% | +0.0% | +76.9% | |
| Dec 2, 2008 | HIO | $4 | $52.2K | NEW | +0.0% | +0.0% | +0.0% | +0.0% | +76.9% | |
| Jul 9, 2007 | HIX | $11 | $11K | NEW | +0.0% | +0.0% | +0.0% | +0.0% | +64.9% | |
| Jul 9, 2007 | EMD | $14 | $9.9K | +233% | +0.0% | +0.0% | +0.0% | +0.0% | +77.7% | |
| Jul 9, 2007 | EHI | $13 | $9.3K | +233% | +0.0% | +0.0% | +0.0% | +0.0% | +67.2% | |
| Jan 23, 2004 | EHI | $15 | $4.6K | NEW | +0.0% | +0.0% | +0.0% | +0.0% | +67.2% | |
| Jan 23, 2004 | EMD | $18 | $5.5K | NEW | +0.0% | +0.0% | +0.0% | +0.0% | +77.7% |
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 15 scored trades, treat this as a small sample, not a verdict.
Full transaction history
All Form 4 activity across every company, newest firstColman Carol L sold $15.5K of DMO, trimming their stake 100%.
Colman Carol L sold $18.4K of EHI, trimming their stake 69%.
Colman Carol L sold $20.4K of CTR, trimming their stake 57%.
Colman Carol L sold $5.1K of HIO, trimming their stake 5%.
Colman Carol L sold $13.1K of HIO, trimming their stake 11%.
Colman Carol L sold $32.9K of HIO, trimming their stake 22%.
Colman Carol L sold $14.4K of EMO, trimming their stake 60%.
Colman Carol L sold $10.4K of HIO, trimming their stake 5%.
Colman Carol L sold $7.7K of HIO, trimming their stake 4%.
Colman Carol L sold $3.3K of HIO, trimming their stake 3%.
Colman Carol L, CTR's Director, spent $33.7K of their own money on 3,000 shares at $11, growing their stake 75%.
Colman Carol L, EMO's Director, spent $21.7K of their own money on 2,000 shares at $11, growing their stake 67%.
Colman Carol L, CEM's Director, spent $29K of their own money on 2,000 shares at $14, growing their stake 33%.
Colman Carol L, CTR's Director, spent $43.9K of their own money on 4,000 shares at $11, opening a brand-new position.
Colman Carol L, EMO's Director, spent $32K of their own money on 3,000 shares at $11, opening a brand-new position.
Colman Carol L, CEM's Director, spent $70.7K of their own money on 5,000 shares at $14, growing their stake 446%.
Colman Carol L, GDO's Director, spent $13.8K of their own money on 800 shares at $17, opening a brand-new position.
Colman Carol L sold $23.1K of CBA, trimming their stake 100%.
Colman Carol L sold $32.9K of DMO, trimming their stake 52%.
Colman Carol L, CBA's Director, spent $37.8K of their own money on 2,000 shares at $19, opening a brand-new position.
Colman Carol L, EHI's Director, spent $41.3K of their own money on 3,000 shares at $14, growing their stake 263%.
Colman Carol L, DMO's Director, spent $32.5K of their own money on 1,500 shares at $22, growing their stake 107%.
Colman Carol L, MNP's Director, spent $48.7K of their own money on 3,000 shares at $16, growing their stake 750%.
Colman Carol L, CEM's Director, spent $43.4K of their own money on 2,000 shares at $22, growing their stake 200%.
Colman Carol L, DMO's Director, spent $28.1K of their own money on 1,400 shares at $20, opening a brand-new position.
Colman Carol L, CEM's Director, spent $20K of their own money on 1,000 shares at $20, opening a brand-new position.
Colman Carol L, HIO's Director, spent $21.3K of their own money on 4,200 shares at $5, growing their stake 19%.
Frequently asked questions
How is COLMAN CAROL L's win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from COLMAN CAROL L's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.